Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04065399
Title A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Syndax Pharmaceuticals
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

Therapies

SNDX-5613

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST